These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9796993)

  • 1. Correspondence re: S. M. Melana et al., Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine. Clin. Cancer Res., 4: 693-696, 1998.
    Olivero OA; Gomez DE
    Clin Cancer Res; 1998 Oct; 4(10):2569-70. PubMed ID: 9796993
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3'-azido-3'-deoxythymidine.
    Melana SM; Holland JF; Pogo BG
    Clin Cancer Res; 1998 Mar; 4(3):693-6. PubMed ID: 9533539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correspondence re: D. S. Swaffar et al., Inhibition of the growth of human pancreatic cancer cells by the arginine antimetabolite L-canavanine. Cancer Res., 54: 6045-6048, 1994.
    Cann SA; van Netten JP; Ross AS
    Cancer Res; 1995 Oct; 55(19):4486-7. PubMed ID: 7671264
    [No Abstract]   [Full Text] [Related]  

  • 4. Simultaneous targeting of telomeres and telomerase as a cancer therapeutic approach.
    Mo Y; Gan Y; Song S; Johnston J; Xiao X; Wientjes MG; Au JL
    Cancer Res; 2003 Feb; 63(3):579-85. PubMed ID: 12566299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
    Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
    Hochreiter AE; Xiao H; Goldblatt EM; Gryaznov SM; Miller KD; Badve S; Sledge GW; Herbert BS
    Clin Cancer Res; 2006 May; 12(10):3184-92. PubMed ID: 16707619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase.
    Ludwig A; Saretzki G; Holm PS; Tiemann F; Lorenz M; Emrich T; Harley CB; von Zglinicki T
    Cancer Res; 2001 Apr; 61(7):3053-61. PubMed ID: 11306487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blocking telomerase by dietary polyphenols is a major mechanism for limiting the growth of human cancer cells in vitro and in vivo.
    Naasani I; Oh-Hashi F; Oh-Hara T; Feng WY; Johnston J; Chan K; Tsuruo T
    Cancer Res; 2003 Feb; 63(4):824-30. PubMed ID: 12591733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase as a new target for pancreatic cancer treatment.
    Sato N; Mizumoto K; Nagai E; Tanaka M
    J Hepatobiliary Pancreat Surg; 2002; 9(3):322-7. PubMed ID: 12353143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase as a therapeutic target. Therapeutic potential of telomerase inhibitors.
    Double JA
    Methods Mol Biol; 2002; 191():209-16. PubMed ID: 11951608
    [No Abstract]   [Full Text] [Related]  

  • 11. Oligonucleotide N3'-->P5' phosphoramidates as efficient telomerase inhibitors.
    Herbert BS; Pongracz K; Shay JW; Gryaznov SM
    Oncogene; 2002 Jan; 21(4):638-42. PubMed ID: 11850790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase therapeutics: telomeres recognized as a DNA damage signal: commentary re: K. Kraemer et al., antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells. Clin. Cancer Res., 9: 3794-3800, 2003.
    Shay JW
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3521-5. PubMed ID: 14506137
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells.
    Izbicka E; Wheelhouse RT; Raymond E; Davidson KK; Lawrence RA; Sun D; Windle BE; Hurley LH; Von Hoff DD
    Cancer Res; 1999 Feb; 59(3):639-44. PubMed ID: 9973212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cells.
    Kim JH; Kim JH; Lee GE; Kim SW; Chung IK
    Biochem J; 2003 Jul; 373(Pt 2):523-9. PubMed ID: 12689331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase as a target for cancer therapy.
    Parkinson KE
    Curr Opin Investig Drugs; 2005 Jun; 6(6):605-10. PubMed ID: 15988912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of telomerase limits the growth of human cancer cells.
    Hahn WC; Stewart SA; Brooks MW; York SG; Eaton E; Kurachi A; Beijersbergen RL; Knoll JH; Meyerson M; Weinberg RA
    Nat Med; 1999 Oct; 5(10):1164-70. PubMed ID: 10502820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consequences of telomerase inhibition and combination treatments for the proliferation of cancer cells.
    Chen Z; Koeneman KS; Corey DR
    Cancer Res; 2003 Sep; 63(18):5917-25. PubMed ID: 14522918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis.
    Mittal A; Pate MS; Wylie RC; Tollefsbol TO; Katiyar SK
    Int J Oncol; 2004 Mar; 24(3):703-10. PubMed ID: 14767556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of telomerase inhibitors on lymphocyte function.
    Beltz L; Moran R; Elsawy O; Sadler J; Jurgenson J
    Anticancer Res; 1999; 19(4B):3205-11. PubMed ID: 10652613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.